Nectar Life sciences Ltd NECLIFE-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 10:36 AM IST
20.25quote price arrow up+0.15 (+0.75%)
Volume
78,521
52 week range
7.10 - 30.05

...

Loading . . .

KEY STATS

  • Open20.30
  • Day High20.65
  • Day Low20.20
  • Prev Close20.10
  • 52 Week High30.05
  • 52 Week High Date06/19/20
  • 52 Week Low7.10
  • 52 Week Low Date03/13/20
  • Market Cap61.08M
  • Shares Out224.26M
  • 10 Day Average Volume470,735.82
  • Dividend0.05
  • Dividend Yield0.25%
  • Beta
  • 1 Year % Change82.43

RATIOS/PROFITABILITY

  • EPS (TTM)-1.12
  • P/E (TTM)-18.15
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/11/2020
  • Div Amount0.05
  • Split Date-
  • Split Factor-

Latest Nectar Life sciences Ltd News

There is no recent news for this security.

Latest NECLIFE-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Nectar Lifesciences Limited is a pharmaceutical company. The Company is engaged in providing drugs and pharmaceuticals. It operates in the business segment of Pharmaceuticals Products. The Company's business activities include contract research and manufacturing services, active pharmaceutical ingredient (API) and intermediates, formulations, generics and over the counter (OTC), diagnostics, empty hard gelatin capsules and menthol. Its products include Cefixime Trihydrate...
Sanjiv Goyal
Chairman
Dinesh Dua
Chief Executive Officer
Sandeep Goel
Chief Financial Officer
Ravi Aggarwal
Vice President
Address
Sco 38-39, Sector 9-D
Chandigarh
160009
India